Insufficient scRNA-seq data for expression of FLRT1 at single-cell level.
Insufficient scRNA-seq data for expression of FLRT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 539.00 | 2634 / 2642 | 96% | 19.46 | 675 / 705 |
adrenal gland | 61% | 111.68 | 157 / 258 | 79% | 35.75 | 181 / 230 |
thymus | 97% | 396.01 | 636 / 653 | 37% | 3.06 | 226 / 605 |
prostate | 95% | 222.20 | 233 / 245 | 36% | 0.58 | 180 / 502 |
skin | 75% | 105.28 | 1352 / 1809 | 46% | 2.84 | 217 / 472 |
intestine | 95% | 402.81 | 920 / 966 | 23% | 0.45 | 119 / 527 |
esophagus | 89% | 211.16 | 1282 / 1445 | 17% | 0.34 | 31 / 183 |
uterus | 80% | 174.84 | 136 / 170 | 25% | 1.08 | 113 / 459 |
kidney | 96% | 227.80 | 85 / 89 | 5% | 0.25 | 44 / 901 |
stomach | 73% | 137.10 | 262 / 359 | 20% | 0.52 | 58 / 286 |
eye | 0% | 0 | 0 / 0 | 93% | 5.79 | 74 / 80 |
bladder | 71% | 108.71 | 15 / 21 | 20% | 0.42 | 103 / 504 |
pancreas | 62% | 89.00 | 203 / 328 | 17% | 0.39 | 31 / 178 |
ovary | 54% | 63.91 | 97 / 180 | 19% | 0.83 | 82 / 430 |
heart | 69% | 92.93 | 591 / 861 | 0% | 0 | 0 / 0 |
liver | 60% | 80.27 | 135 / 226 | 6% | 0.09 | 24 / 406 |
breast | 51% | 62.55 | 235 / 459 | 8% | 0.16 | 85 / 1118 |
lung | 32% | 34.54 | 187 / 578 | 15% | 0.42 | 172 / 1155 |
adipose | 40% | 46.08 | 481 / 1204 | 0% | 0 | 0 / 0 |
spleen | 34% | 36.58 | 82 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 21% | 21.04 | 275 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.18 | 6 / 45 |
muscle | 10% | 11.73 | 83 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 1.03 | 15 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1990138 | Biological process | neuron projection extension |
GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
GO_0007155 | Biological process | cell adhesion |
GO_0016358 | Biological process | dendrite development |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005615 | Cellular component | extracellular space |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0044306 | Cellular component | neuron projection terminus |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0031012 | Cellular component | extracellular matrix |
GO_0032809 | Cellular component | neuronal cell body membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
Gene name | FLRT1 |
Protein name | Leucine-rich repeat transmembrane protein FLRT1 (Fibronectin-like domain-containing leucine-rich transmembrane protein 1) |
Synonyms | UNQ752/PRO1483 |
Description | FUNCTION: Plays a role in fibroblast growth factor-mediated signaling cascades that lead to the activation of MAP kinases. Promotes neurite outgrowth via FGFR1-mediated activation of downstream MAP kinases. Promotes an increase both in neurite number and in neurite length. May play a role in cell-cell adhesion and cell guidance via its interaction with ADGRL1/LPHN1 and ADGRL3. . |
Accessions | ENST00000246841.3 [Q9NZU1-2] ENST00000682287.1 [Q9NZU1-2] Q9NZU1 |